openPR Logo
Press release

Biologics Market Trends, Business Overview, Industry Growth and Forecast to 2027

06-09-2021 09:56 AM CET | Health & Medicine

Press release from: Orion Market Reports

The Biologics Market was valued at approximately USD 302.63 billion in 2020, and it is expected to reach USD 509.23 billion by 2027, registering a CAGR of 9% during the forecast period, 2021-2027.

Biologics are drugs that exist in the form of genetically engineered proteins derived from human genes. According to the US FDA, biologics may consist of sugars, proteins or nucleic acids, or complex combinations of these substances, or they may consist of living entities such as cells and tissues. Most biologics are complex mixtures that cannot be readily characterized or identified, are heat sensitive, and susceptible to microbial contamination. A biological product derived from a variety of natural sources, such as animals, humans, or microorganisms. These products consist of vaccines, blood and blood components, allergies, somatic cells, gene therapy, tissue, and recombinant therapeutic proteins. Processes such as advanced biotechnology and complex processes are used to manufacture biological products. Biologics' diverse products are monoclonal antibodies, vaccines, recombinant hormones/proteins, gene-based biologics, cell-based biologics, and others. They are used in applications such as autoimmune diseases, cancer, infectious diseases, rare diseases, and others.

(Get 15% Discount on Buying this Report)
A full report of Global Biologics Market is available at: https://www.orionmarketreports.com/biologics-market/56617/

Market Segments

By Product Type
• Monoclonal Antibodies
• Vaccines
• Recombinant Hormones/Proteins
• Cellular Based Biologics
• Gene-Based Biologics

By Application
• Cancer
• Infectious Diseases
• Autoimmune Diseases
• Others

By End-use
• Hospitals
• Clinics
• Diagnostic Centers
• Others

Key Players

Key players operating in the global biologics market include Bristol-Myers Squibb Company (BMS), Merck & Co., Inc., Roche AG, Merck KGaA, AstraZeneca Plc, Regeneron Pharmaceuticals, Inc, Novartis International AG, Pfizer, Inc., Amgen, Inc., AbbVie, Inc., Sanofi S.A., Eli Lilly & Company, Novo Nordisk A/S, Johnson & Johnson, GlaxoSmithKline Plc, Teva Pharmaceutical Industries Ltd., Ipsen S.A., and Allergan Plc.

Scope of the Report

The research study analyzes the global Biologics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Biologics Market Report

1. What was the Biologics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of the Biologics Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Biologics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report covers the following objectives:

• Proliferation and maturation of trade in the global Biologics market.
• The market share of the global Biologics market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Biologics market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Biologics market.

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:

Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biologics Market Trends, Business Overview, Industry Growth and Forecast to 2027 here

News-ID: 2301216 • Views:

More Releases from Orion Market Reports

SOx Control Systems Market Value Projected to Expand by 2031
SOx Control Systems Market Value Projected to Expand by 2031
The SOx Control Systems Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2024-2031). SOx control systems refer to technologies and methods used to reduce emissions of sulfur oxides (SOx) from industrial processes, particularly from the combustion of fossil fuels. Sulfur oxides, including sulfur dioxide (SO2) and sulfur trioxide (SO3), are air pollutants that contribute to acid rain, air quality degradation, and
Solar Wafer Cutting Fluid (PEG) Market Sluggish Growth Rate Foreseen by 2024-2031
Solar Wafer Cutting Fluid (PEG) Market Sluggish Growth Rate Foreseen by 2024-203 …
The Solar Wafer Cutting Fluid (PEG) Market size is expected to grow at an annual average of CAGR 7% during the forecast period (2024-2031). Solar wafer cutting fluid (PEG) refers to a type of cutting fluid used in the manufacturing process of silicon wafers for solar cell production. PEG stands for Polyethylene Glycol, which is a polymer compound with various applications in industries such as pharmaceuticals, cosmetics, and manufacturing. Establishing business
Pusher Furnaces Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2024 to 2031)
Pusher Furnaces Market is Anticipated to Increase at a Stable CAGR over the Fore …
The Pusher Furnaces Market size is expected to grow at an annual average of CAGR 12% during the forecast period (2024-2031). Pusher furnaces are a type of industrial furnace used for continuous heating and processing of materials in a production environment. These furnaces are designed to handle high-volume production of components or materials that require uniform heating, annealing, tempering, or other heat treatment processes. Establishing business of any size in the
Power Transmission Cables Market to Signify Strong Growth by 2024-2031
Power Transmission Cables Market to Signify Strong Growth by 2024-2031
The Power Transmission Cables Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2024-2031). Power transmission cables are electrical conductors used to transmit electricity from power generation sources to various points of consumption, such as industrial facilities, residential buildings, commercial complexes, and substations. These cables form an integral part of the electrical grid infrastructure, facilitating the efficient and reliable distribution of electricity

All 5 Releases


More Releases for Biologics

Biopharmaceutical CMO Market 2020 Business Scenario – Lonza, Boehringer Ingelh …
The report provides a valuable source of insightful data for business strategists and competitive analysis of Biopharmaceutical CMO Market. It provides the Biopharmaceutical CMO industry overview with growth analysis and futuristic cost, revenue and many other aspects. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tire Biopharmaceutical CMO study provides comprehensive data which enhances the understanding, scope and application of this report. the
Extracellular Matrix Market Detailed Analysis 2020: Top Companies like Coloplast …
The global extracellular matrix market by raw material segments was led by porcine segment. In 2018, the porcine segment held a largest market share of 41.09% of the extracellular matrix market, by raw material. However, the bovine segment is expected to be the fastest growing segments of the market in 2027 owing to more beneficial properties to treat various conditions which is expected to become the major factor for the
Biopharmaceutical CMO Market 2018-2023 :Lonza, Boehringer Ingelheium, Samsung Bi …
Global Biopharmaceutical CMO Industry - A Global Market Overview (2018-2023) (Avail A 10% Off) The "Global Biopharmaceutical CMO Market Research Report 2018-2023" is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides
Global Biopharmaceutical CMO Market Key Profiles - Wuxi Biologics, Boehringer In …
Global Biopharmaceutical CMO Market was valued at USD 13296.29 million in the year 2019. Escalating number of patients suffering from various diseases with growing investment in the healthcare industry by government in major economies and increasing awareness among consumers regarding impact of various viruses on health, has been anticipated to infuse growth in the market for Biopharmaceutical CMO during the forecasting period of 2020-2025. Get Free Sample Copy of this Research
Plant-based Biologics
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development
Global Biopharmaceutical CMO Market 2018-2023| Lonza, Boehringer Ingelheium, Sam …
Albany, NY, 10th September : Recent research and the current scenario as well as future market potential of "Global Biopharmaceutical CMO Market - Analysis By Region, By Country: Opportunities and Forecast (2018-2023) - By Region (North America, Europe, APAC), By Country (U.S, Denmark, Germany, Switzerland, Korea, Japan, China)" globally. A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to